GDF-8
Also known as Myostatin, Growth Differentiation Factor 8
A TGF-beta family protein better known as myostatin, the major negative regulator of skeletal muscle growth and a target in muscle-wasting research.
Overview
GDF-8 is myostatin, a TGF-beta family protein that acts as a major brake on skeletal muscle growth. It is not a typical peptide product; it is usually discussed as a target.
The Science
Blocking myostatin signaling can increase muscle mass in animal models and certain genetic contexts, but translating that safely into human therapy is difficult.
- Muscle growth regulation - myostatin limits hypertrophy.
- Wasting disorders - target for muscular dystrophy, cachexia, and sarcopenia research.
- Pathway breadth - TGF-beta family signaling is biologically interconnected.
Evidence Snapshot
GDF-8 is more accurately a pathway target than a wellness product. Claims around "myostatin blockers" need careful evidence review.
Related
More in Growth Hormone
ACE-031
InvestigationalGrowth Hormone
Not a peptideFusion protein
An investigational soluble activin receptor type IIB fusion protein studied for blocking myostatin-family ligands and increasing muscle mass in wasting disorders.
CJC-1295
Research compoundGrowth Hormone
A synthetic analog of growth-hormone-releasing hormone (GHRH) engineered for extended half-life, studied for prolonged stimulation of pulsatile GH and IGF-1 release — a tool researchers and self-experimenters use to explore their own endocrine biology.
GHRP-6
Research compoundGrowth Hormone
A growth hormone secretagogue peptide that activates ghrelin/GHS receptors and is studied for GH release, appetite signaling, and endocrine-axis pharmacology.